Who should take the AREDS formulation?
People at high risk for developing advanced AMD should consider taking the AREDS formulation. Advise your patient to see his eye care provider, who can tell him if he has AMD and is at risk for developing the advanced form of the disease. Warn the patient not to start taking the AREDS formulation before speaking with his eye care and other health care providers.
People who are at high risk for developing advanced AMD should consider taking the formulation. You are at high risk for developing advanced AMD if you have either: 1. Intermediate AMD in one or both eyes. OR 2. Advanced AMD (dry or wet) in one eye but not the other eye. Your eye care professional can tell you if you have AMD, its stage, and your risk for developing the advanced form. The AREDS formulation is not a cure for AMD. It will not restore vision already lost from the disease. However, it may delay the onset of advanced AMD. It may help people who are at high risk for developing advanced AMD keep their vision. Can people with early stage AMD take the AREDS formulation to help prevent the disease from progressing to the intermediate stage? There is no apparent need for those diagnosed with early stage AMD to take the AREDS formulation. The study did not find that the formulation provided a benefit to those with early stage AMD. If you have early stage AMD, a comprehensive dilat
